Mackenzie Financial Corp Purchases 509,868 Shares of Inari Medical, Inc. (NASDAQ:NARI)

Mackenzie Financial Corp increased its position in shares of Inari Medical, Inc. (NASDAQ:NARI) by 59.7% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,363,697 shares of the company’s stock after buying an additional 509,868 shares during the quarter. Mackenzie Financial Corp’s holdings in Inari Medical were worth $69,617,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of NARI. PNC Financial Services Group Inc. boosted its holdings in Inari Medical by 5.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,550 shares of the company’s stock valued at $130,000 after acquiring an additional 128 shares during the period. Arizona State Retirement System lifted its position in shares of Inari Medical by 0.9% during the 4th quarter. Arizona State Retirement System now owns 15,196 shares of the company’s stock worth $776,000 after purchasing an additional 129 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in Inari Medical by 12.3% during the 4th quarter. Quadrant Capital Group LLC now owns 1,301 shares of the company’s stock valued at $66,000 after purchasing an additional 143 shares during the period. Ieq Capital LLC grew its holdings in Inari Medical by 0.3% in the 4th quarter. Ieq Capital LLC now owns 50,198 shares of the company’s stock valued at $2,563,000 after buying an additional 145 shares during the last quarter. Finally, HighTower Advisors LLC grew its holdings in Inari Medical by 0.4% in the 4th quarter. HighTower Advisors LLC now owns 62,202 shares of the company’s stock valued at $3,175,000 after buying an additional 234 shares during the last quarter. 90.98% of the stock is currently owned by institutional investors and hedge funds.

Inari Medical Price Performance

Shares of NARI stock opened at $79.97 on Friday. Inari Medical, Inc. has a 12 month low of $39.76 and a 12 month high of $79.99. The firm has a market cap of $4.68 billion, a PE ratio of -59.24 and a beta of 1.02. The stock has a 50 day moving average of $79.97 and a 200-day moving average of $71.76.

Inari Medical Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.